Business Description
3D Global Biotech Inc
ISIN : TW0006808009
Share Class Description:
ROCO:6808: Ordinary SharesTotal Employee Number:
45Description
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.81 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.6 | |||||
Interest Coverage | 31.56 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 17.77 | |||||
Beneish M-Score | -1.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 120 | |||||
3-Year Book Growth Rate | 28.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.54 | |||||
9-Day RSI | 68.53 | |||||
14-Day RSI | 68.78 | |||||
3-1 Month Momentum % | -22.76 | |||||
6-1 Month Momentum % | -47.21 | |||||
12-1 Month Momentum % | -51.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 14.08 | |||||
Quick Ratio | 13.53 | |||||
Cash Ratio | 11.7 | |||||
Days Inventory | 139.84 | |||||
Days Sales Outstanding | 125.71 | |||||
Days Payable | 41.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.34 | |||||
Dividend Payout Ratio | 0.61 | |||||
Forward Dividend Yield % | 0.34 | |||||
5-Year Yield-on-Cost % | 0.33 | |||||
3-Year Average Share Buyback Ratio | -10.9 | |||||
Shareholder Yield % | 2.11 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.79 | |||||
Operating Margin % | 21.39 | |||||
Net Margin % | 32.18 | |||||
EBITDA Margin % | 39.35 | |||||
FCF Margin % | 50.6 | |||||
OCF Margin % | 53.65 | |||||
ROE % | 7.14 | |||||
ROA % | 6.26 | |||||
ROIC % | 11.82 | |||||
3-Year ROIIC % | 22.75 | |||||
ROC (Joel Greenblatt) % | 39.68 | |||||
ROCE % | 5.34 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 46.25 | |||||
PE Ratio without NRI | 44.76 | |||||
Price-to-Owner-Earnings | 26.21 | |||||
PS Ratio | 14.88 | |||||
PB Ratio | 3.05 | |||||
Price-to-Tangible-Book | 3.28 | |||||
Price-to-Free-Cash-Flow | 29.46 | |||||
Price-to-Operating-Cash-Flow | 27.79 | |||||
EV-to-EBIT | 47.71 | |||||
EV-to-EBITDA | 31.48 | |||||
EV-to-Revenue | 12.4 | |||||
EV-to-FCF | 24.13 | |||||
Price-to-GF-Value | 0.21 | |||||
Price-to-Projected-FCF | 4.23 | |||||
Price-to-Graham-Number | 2.55 | |||||
| Price-to-Net-Current-Asset-Value | 6.39 | |||||
| Price-to-Net-Cash | 8.06 | |||||
Earnings Yield (Greenblatt) % | 2.1 | |||||
FCF Yield % | 3.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3D Global Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 206.735 | ||
| EPS (TTM) (NT$) | 0.84 | ||
| Beta | 0.3403 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.59 | ||
| Volatility % | 35.29 | ||
| 14-Day RSI | 68.78 | ||
| 14-Day ATR (NT$) | 2.650522 | ||
| 20-Day SMA (NT$) | 34.185 | ||
| 12-1 Month Momentum % | -51.29 | ||
| 52-Week Range (NT$) | 22.45 - 63 | ||
| Shares Outstanding (Mil) | 76.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3D Global Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3D Global Biotech Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.132000 Cash Dividend | 2026-07-16 | 40.30 (+4.68%) | ||
| TWD 0.530000 Cash Dividend | 2025-07-07 | 54.00 (-2.17%) |
Show
Entries
3D Global Biotech Inc Frequently Asked Questions
What is 3D Global Biotech Inc(ROCO:6808)'s stock price today?
The current price of ROCO:6808 is NT$38.85. The 52 week high of ROCO:6808 is NT$63.00 and 52 week low is NT$22.45.
When is next earnings date of 3D Global Biotech Inc(ROCO:6808)?
The next earnings date of 3D Global Biotech Inc(ROCO:6808) is .
Does 3D Global Biotech Inc(ROCO:6808) pay dividends? If so, how much?
The Dividend Yield %  of 3D Global Biotech Inc(ROCO:6808) is 0.34% (As of Today), Highest Dividend Payout Ratio of 3D Global Biotech Inc(ROCO:6808) was 0.61. The lowest was 0.61. And the median was 0.61. The  Forward Dividend Yield % of 3D Global Biotech Inc(ROCO:6808) is 0.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on 3D Global Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers